# Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study

> **NCT04080544** · PHASE2 · COMPLETED · sponsor: **Neil M Rofsky, MD, MHA** · enrollment: 125 (actual)

## Conditions studied

- Alzheimer Disease
- Cognitive Decline

## Interventions

- **DRUG:** [18F]AV-1451
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT04080544
- **Lead sponsor:** Neil M Rofsky, MD, MHA
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080544, "Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04080544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*